Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Journal of Pediatric Endocrinology & Metabolism : JPEM|November 6, 2004
Low bone mass in prepubertal children with thalassemia major: insights into the pathogenesis of low bone mass in thalassemiaMaria G Vogiatzi, Karen A Autio, Robert Schneider, et al.Pediatric Blood & Cancer|May 3, 2013
The palatability and tolerability of deferasirox taken with different beverages or foodsStuart L Goldberg, Patricia J Giardina, Deborah Chirnomas, et al.Annals of the New York Academy of Sciences|August 18, 2010
Combined iron chelation therapyRenzo Galanello, Annalisa Agus, Simona Campus, et al.Annals of the New York Academy of Sciences|December 13, 2005
Low bone mineral density in adolescents with beta-thalassemiaMaria G Vogiatzi, Karen A Autio, Jeffrey E Mait, et al.Haematologica|August 10, 2012
Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamineRobert W Grady, Renzo Galanello, Rachel E Randolph, et al.American Journal of Hematology|May 4, 2013
Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year studySrikanth R Ambati, Rachel E Randolph, Kevin Mennitt, et al.Annals of the New York Academy of Sciences|August 18, 2010
Hepcidin and Hfe in iron overload in beta-thalassemiaSara Gardenghi, Pedro Ramos, Antonia Follenzi, et al.Calcified Tissue International|May 8, 2010
Changes in bone microarchitecture and biomechanical properties in the th3 thalassemia mouse are associated with decreased bone turnover and occur during the period of bone accrualMaria G Vogiatzi, Jaime Tsay, Kostas Verdelis, et al.The Journal of Pediatrics|June 16, 2010
Relationship between chronic transfusion therapy and body composition in subjects with thalassemiaEllen B Fung, Yan Xu, Janet L Kwiatkowski, et al.Pageof 4